Header

UZH-Logo

Maintenance Infos

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG


Blumenthal, Deborah T; Gorlia, Thierry; Gilbert, Mark R; Kim, Michelle M; Burt Nabors, L; Mason, Warren P; Hegi, Monika E; Zhang, Peixin; Golfinopoulos, Vassilis; Perry, James R; Hyun Nam, Do; Erridge, Sara C; Corn, Benjamin W; Mirimanoff, René O; Brown, Paul D; Baumert, Brigitta G; Mehta, Minesh P; van den Bent, Martin J; Reardon, David A; Weller, Michael; Stupp, Roger (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology, 19(8):1119-1126.

Statistics

Citations

Dimensions.ai Metrics
14 citations in Web of Science®
9 citations in Scopus®
13 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 09 Nov 2017
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:1 August 2017
Deposited On:09 Nov 2017 07:26
Last Modified:19 Feb 2018 08:58
Publisher:Oxford University Press
ISSN:1522-8517
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/neuonc/nox025
PubMed ID:28371907

Download